Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology

Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for daily use in cancer treatment in recent years; consequently, new cases of ONJ have been rep...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Korean Assoc Oral Maxillofac Surg
Egile Nagusiak: Nifosì, Antonio Fabrizio, Zuccarello, Mariateresa, Nifosì, Lorenzo, Hervas Saus, Vanessa, Nifosì, Gianfilippo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Association of Oral and Maxillofacial Surgeons 2019
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6400698/
https://ncbi.nlm.nih.gov/pubmed/30847290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5125/jkaoms.2019.45.1.3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak